Table 2 Clinical outcomes analysis with propensity score matched cohorts
Outcomes | CVP | NO CVP | Effect size | p value |
|---|---|---|---|---|
Primary outcome | ||||
28-day mortality | 396/2174 (18.2) | 500/2174 (23) | 0.118 | < 0.001 |
Secondary outcomes | ||||
In-hospital mortality | 366/2174 (16.8) | 415/2174 (19.1) | 0.059 | 0.058 |
1-year mortality | 789/2174 (36.3) | 920/2174 (42.3) | 0.124 | < 0.001 |
AKI within 7 days, n (%) | 1722/2174 (79.2) | 1692/2174 (77.8) | 0.029 | 0.355 |
Volume of IVF on day 1(mL) | 2380 (1037–4245) | 1897.5 (890–3070) | 0.327 | < 0.001 |
Volume of IVF on day 2 (mL) | 997 (289.2–2150) | 1000 (268.25–1953.6) | 0.142 | 0.054 |
Volume of IVF on day 3 (mL) | 605 (240–1500) | 625 (230–1580.5) | 0.051 | 0.942 |
Vasopressor-free day in 28 days | 26.6 (25–27.4) | 26.2 (22.9–27.2) | 0.472 | < 0.001 |
Ventilation-free day in 28 days | 25.8 (22.3–27.1) | 23.3 (17.3–26.2) | 0.291 | < 0.001 |
Delta-lactate | 1.48 (2.35) | 1.13 (2.32) | 0.148 | 0.029 |